Trial Profile
AnakInRa for Treatment of Recurrent Idiopathic Pericarditis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Pericarditis
- Focus Therapeutic Use
- Acronyms AIR TRIP
- 18 Mar 2021 A systematic review and meta- analysis of randomised controlled trials and observational studies assessing pericarditis recurrences and drug- related adverse events in patients receiving anti- IL-1 drugs for pericarditis, published in the Heart.
- 08 Nov 2016 Results published in the JAMA: the Journal of the American Medical Association
- 03 Feb 2016 New trial record